Document is current
Any future updates will be listed below
-
Authors
Zhang, Huan
Santana-Codina, Naiara https://orcid.org/0000-0002-8250-4530
Yu, Qijia
Poupault, Clara https://orcid.org/0000-0003-3145-9773
Campos, Claudia
Qin, Xingping https://orcid.org/0000-0003-3263-0843
Sindoni, Nicole https://orcid.org/0009-0005-1450-8221
Ciscar, Marina
Padhye, Aparna
Kuljanin, Miljan
Wang, Junning
Dorman, Matthew J.
Bross, Peter https://orcid.org/0000-0001-9526-8525
Aguirre, Andrew J. https://orcid.org/0000-0002-0701-6203
Dougan, Stephanie K. https://orcid.org/0000-0002-2263-363X
Sarosiek, Kristopher A. https://orcid.org/0000-0002-4618-5085
Mancias, Joseph D. https://orcid.org/0000-0002-0692-3717
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 17 June 2025
First Online: 30 July 2025
Competing interests
: J.D.M. reports research support to his institution from Novartis and Casma Therapeutics and has consulted for Third Rock Ventures and Skyhawk Therapeutics, all unrelated to the submitted work. A.J.A. has consulted for Anji Pharmaceuticals, Affini-T Therapeutics, Arrakis Therapeutics, AstraZeneca, Boehringer Ingelheim, Kestrel Therapeutics, Merck & Co., Inc., Mirati Therapeutics Inc., Nimbus Therapeutics, Oncorus, Inc., Plexium, Quanta Therapeutics, Revolution Medicines, Reactive Biosciences, Riva Therapeutics, Servier Pharmaceuticals, Syros Pharmaceuticals, T-knife Therapeutics, Third Rock Ventures, and Ventus Therapeutics; holds equity in Riva Therapeutics and Kestrel Therapeutics; and has research funding from Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Deerfield, Inc., Eli Lilly, Mirati Therapeutics Inc., Novartis, Novo Ventures, Revolution Medicines, and Syros Pharmaceuticals, all unrelated to the submitted work. S.K.D. has received research funding from Novartis, Bristol Myers Squibb, Casma Therapeutics and Takeda, has equity in Axxis Bio, and is a co-founder and SAB member for Kojin Therapeutics, all unrelated to the submitted work. All authors declare no competing interests.
